
Join to View Full Profile
425 George StreetNew Haven, CT 06511
Dr. Bassir Nia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Tehran University of Medical Sciences School of MedicineClass of 2004
- Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Addiction Psychiatry
Certifications & Licensure
- CT State Medical License 2018 - 2025
- NY State Medical License 2016 - 2018
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- OMAR Opioid Use Disorder Start of enrollment: 2023 Mar 10
Roles: Contact, Principal Investigator
- The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) Start of enrollment: 2025 May 15
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.Jeremy Weleff, Alejandra Pulido-Saavedra, Ardavan Mohammad Aghaei, Kevin Ing, Miranda Arakelian
Psychiatry Research. 2025-03-15 - Effects of psychedelics on opioid use disorder: a scoping review of preclinical studies.Alejandra Pulido-Saavedra, Henrique Nunes Pereira Oliva, Tiago Paiva Prudente, Razi Kitaneh, Eric J Nunes
Cellular and Molecular Life Sciences. 2025-01-21 - 4 citationsCannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis.Anahita Bassir Nia, Claire L Gibson, Sharron A Spriggs, Samantha E Jankowski, Daniel DeFrancisco
Journal of Psychopharmacology. 2023-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: